Alumis
ALMS· Manufacturing· Fiscal year ends in December
CEO pay in FY2025Stock +24.2% in FY2025
Martin Babler is the CEO of Alumis and was paid $5.9M in FY2025 (Dec), down 44%.
Pay$100 in the stock at the end of FY24 → $124
Executives3
See all- 1Martin BablerPresident, Chief Executive Officer, and Chairman of the BoardFY2025
- 2David M. Goldstein, Ph.D.Chief Scientific OfficerFY2025
- 3Jörn Drappa, M.D., Ph.D.Chief Medical OfficerFY2025
Named executives and their total pay, from the Summary Compensation Table of the latest proxy.
Pay
See allAlumis paid its 3 named executives $9.9M in total in FY2025 (Dec). CEO Martin Babler was paid $5.9M of that.
| Name | |||
|---|---|---|---|
| Martin BablerPresident, Chief Executive Officer, and Chairman of the Board | |||
| David M. Goldstein, Ph.D.Chief Scientific Officer | |||
| Jörn Drappa, M.D., Ph.D.Chief Medical Officer | Not disclosed | Not disclosed |
of each named executive, from the Summary Compensation Table of each proxy.
Peers
No disclosed peer group
No proxy on file names a pay peer group for Alumis. The peer group comes from the proxy statement, so it shows here when a proxy read has it.
Board2
See all- Sapna Srivastava, Ph.D.Lead independent director · 3 yr on the boardIndependentNominating and Corporate Governance—Paid as an executive
- Alan B. Colowick, M.D., M.P.H.Director · 4 yr on the boardIndependentAudit, Compensation, Science and Technology—Paid as an executive
The board of the latest proxy (FY2025).
Activity
Filings4
See all| Proxy statement | DEF 14A | May 18, 2026 | FY2025 |
| Annual report | 10-K | Mar 19, 2026 | FY2025 |
| Proxy statement | DEF 14A | Jun 16, 2025 | FY2024 |
| Annual report | 10-K | Mar 19, 2025 | FY2024 |
